The ESMO Gastrointestinal Cancers Congress 2024 programme is online!
The ESMO Gastrointestinal Cancers Congress is a place for the global GI oncology community to present and discuss impactful new research data in gastrointestinal oncology, in a comprehensive programme also rich in high-quality educational sessions. The congress offers excellent networking opportunities in an international environment.
In the Keynote lectures, Educational sessions, Multidisciplinary Tumour Board sessions, Special Symposia, Scientific sessions and Poster exhibition, attendees will be able to update their knowledge on:
- To update oncology health care professionals on recent developments in state of the art management of patients with gastrointestinal malignancies
- To present latest insights in the molecular prevention, diagnosis and precision therapy of gastrointestinal cancers
- To provide in-depth expert knowledge in controversy areas in gastrointestinal oncology
ESMO-MORA: The ESMO Gastrointestinal Cancers 2024 Congress programme will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.
All Speakers and Discussants are required to declare their interests, if any, and include a Declaration of Interest (DOI) slide at the start of their presentation(s).
The experts invited by ESMO as Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons.
The ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.